Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) Stock Price, Quote & AI Analysis

Live RDY stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Dr. Reddy's Laboratories Limited American Depositary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Dr. Reddy's Laboratories Limited American Depositary Shares (RDY), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

R
RDY
Dr. Reddy's Laboratories Limited American Depositary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
13.700000
High
13.875000
Low
13.650000
Volume
3,633,210
VWAP
-
Market Cap
$11,331,253,065.90
52W Range
$12.26 - $16.17
P/E Ratio
-
EPS
-
Dividend Yield
52.53%
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Dr. Reddy's Laboratories Limited American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Dr. Reddy's Laboratories Limited American Depositary Shares Overview

Company information

Company Overview

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Company Details
Market Cap
$11.49B
Shares Outstanding
832,380,075
Weighted Shares Outstanding
832,568,190
CEO
Erez Israeli
Employees
27,811
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Dr. Reddy's Laboratories Limited American Depositary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...